Specialty Pharmaceutical Company with a Focus in Pain and Addiction

Filing date Description Form Filing Group Filer View

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-239740.pdf 0001193125-18-239740.rtf 0001193125-18-239740.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Watson W. Mark 0000899243-18-021411.pdf 0000899243-18-021411.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Davis Todd C 0000899243-18-021412.pdf 0000899243-18-021412.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Greenleaf Peter 0000899243-18-021409.pdf 0000899243-18-021409.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Broadfin Capita 0000899243-18-021408.pdf 0000899243-18-021408.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Smith Thomas B 0000899243-18-021008.pdf 0000899243-18-021008.rtf View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Smith Thomas B 0000899243-18-021006.pdf 0000899243-18-021006.rtf View HTML

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
0001193125-18-211557.pdf 0001193125-18-211557.rtf 0001193125-18-211557.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-18-018489.pdf 0000899243-18-018489.rtf View HTML

A preliminary proxy statement providing notification matters to be brought to a vote

PRE 14A
Proxy Filings
0001193125-18-198130.pdf 0001193125-18-198130.rtf 0001193125-18-198130.xls View HTML

Copyright Morningstar

Investor Presentation

There are no items to display.

Get the latest details on our products and services.

SIGN UP